nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP3A4—Ifosfamide—testicular cancer	0.0758	0.218	CbGbCtD
Cyclobenzaprine—CYP1A2—Etoposide—testicular cancer	0.0691	0.199	CbGbCtD
Cyclobenzaprine—CYP2D6—Vinblastine—testicular cancer	0.0632	0.182	CbGbCtD
Cyclobenzaprine—CYP3A4—Vinblastine—testicular cancer	0.0402	0.116	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—testicular cancer	0.0389	0.112	CbGbCtD
Cyclobenzaprine—CYP3A4—Etoposide—testicular cancer	0.0362	0.104	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—testicular cancer	0.0247	0.071	CbGbCtD
Cyclobenzaprine—Hypersensitivity—Dactinomycin—testicular cancer	0.000997	0.00153	CcSEcCtD
Cyclobenzaprine—Gastritis—Epirubicin—testicular cancer	0.000988	0.00152	CcSEcCtD
Cyclobenzaprine—Confusional state—Etoposide—testicular cancer	0.000987	0.00151	CcSEcCtD
Cyclobenzaprine—Urticaria—Ifosfamide—testicular cancer	0.000985	0.00151	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Ifosfamide—testicular cancer	0.00098	0.0015	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Methotrexate—testicular cancer	0.000979	0.0015	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Etoposide—testicular cancer	0.000979	0.0015	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000974	0.00149	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—testicular cancer	0.000971	0.00149	CcSEcCtD
Cyclobenzaprine—Asthenia—Dactinomycin—testicular cancer	0.00097	0.00149	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Cisplatin—testicular cancer	0.00096	0.00147	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Etoposide—testicular cancer	0.000959	0.00147	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000958	0.00147	CcSEcCtD
Cyclobenzaprine—Tachycardia—Etoposide—testicular cancer	0.000955	0.00147	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Epirubicin—testicular cancer	0.000955	0.00147	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Cisplatin—testicular cancer	0.000953	0.00146	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—testicular cancer	0.00095	0.00146	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Etoposide—testicular cancer	0.000946	0.00145	CcSEcCtD
Cyclobenzaprine—Anorexia—Etoposide—testicular cancer	0.000933	0.00143	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Cisplatin—testicular cancer	0.000929	0.00142	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dactinomycin—testicular cancer	0.000925	0.00142	CcSEcCtD
Cyclobenzaprine—Vomiting—Bleomycin—testicular cancer	0.000922	0.00141	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—testicular cancer	0.000919	0.00141	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Epirubicin—testicular cancer	0.000916	0.00141	CcSEcCtD
Cyclobenzaprine—Hypotension—Etoposide—testicular cancer	0.000915	0.0014	CcSEcCtD
Cyclobenzaprine—Rash—Bleomycin—testicular cancer	0.000914	0.0014	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—testicular cancer	0.000914	0.0014	CcSEcCtD
Cyclobenzaprine—Dermatitis—Bleomycin—testicular cancer	0.000914	0.0014	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ifosfamide—testicular cancer	0.000913	0.0014	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000897	0.00138	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—testicular cancer	0.000896	0.00137	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Epirubicin—testicular cancer	0.000891	0.00137	CcSEcCtD
Cyclobenzaprine—Asthenia—Ifosfamide—testicular cancer	0.000889	0.00136	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—testicular cancer	0.000884	0.00136	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—testicular cancer	0.000881	0.00135	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Cisplatin—testicular cancer	0.000881	0.00135	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Etoposide—testicular cancer	0.000879	0.00135	CcSEcCtD
Cyclobenzaprine—Weight increased—Epirubicin—testicular cancer	0.000878	0.00135	CcSEcCtD
Cyclobenzaprine—Pruritus—Ifosfamide—testicular cancer	0.000877	0.00135	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Etoposide—testicular cancer	0.000873	0.00134	CcSEcCtD
Cyclobenzaprine—Somnolence—Etoposide—testicular cancer	0.00087	0.00133	CcSEcCtD
Cyclobenzaprine—Nausea—Bleomycin—testicular cancer	0.000861	0.00132	CcSEcCtD
Cyclobenzaprine—Drowsiness—Epirubicin—testicular cancer	0.00086	0.00132	CcSEcCtD
Cyclobenzaprine—Vomiting—Dactinomycin—testicular cancer	0.00086	0.00132	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—testicular cancer	0.000858	0.00132	CcSEcCtD
Cyclobenzaprine—Rash—Dactinomycin—testicular cancer	0.000853	0.00131	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Etoposide—testicular cancer	0.000851	0.00131	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ifosfamide—testicular cancer	0.000848	0.0013	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—testicular cancer	0.000848	0.0013	CcSEcCtD
Cyclobenzaprine—Fatigue—Etoposide—testicular cancer	0.000844	0.00129	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000843	0.00129	CcSEcCtD
Cyclobenzaprine—Stomatitis—Epirubicin—testicular cancer	0.000839	0.00129	CcSEcCtD
Cyclobenzaprine—Jaundice—Epirubicin—testicular cancer	0.000839	0.00129	CcSEcCtD
Cyclobenzaprine—Constipation—Etoposide—testicular cancer	0.000837	0.00128	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00083	0.00127	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—testicular cancer	0.000825	0.00127	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—testicular cancer	0.000825	0.00127	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—testicular cancer	0.000825	0.00127	CcSEcCtD
Cyclobenzaprine—Dizziness—Ifosfamide—testicular cancer	0.00082	0.00126	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—testicular cancer	0.000819	0.00126	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—testicular cancer	0.000813	0.00125	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Etoposide—testicular cancer	0.000807	0.00124	CcSEcCtD
Cyclobenzaprine—Nausea—Dactinomycin—testicular cancer	0.000803	0.00123	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—testicular cancer	0.000803	0.00123	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Etoposide—testicular cancer	0.000801	0.00123	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—testicular cancer	0.000796	0.00122	CcSEcCtD
Cyclobenzaprine—Vomiting—Ifosfamide—testicular cancer	0.000788	0.00121	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Cisplatin—testicular cancer	0.000787	0.00121	CcSEcCtD
Cyclobenzaprine—Rash—Ifosfamide—testicular cancer	0.000782	0.0012	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ifosfamide—testicular cancer	0.000781	0.0012	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00078	0.0012	CcSEcCtD
Cyclobenzaprine—Urticaria—Etoposide—testicular cancer	0.000778	0.00119	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—testicular cancer	0.000776	0.00119	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—testicular cancer	0.000776	0.00119	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Etoposide—testicular cancer	0.000774	0.00119	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—testicular cancer	0.000772	0.00118	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—testicular cancer	0.00077	0.00118	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—testicular cancer	0.000769	0.00118	CcSEcCtD
Cyclobenzaprine—Asthenia—Cisplatin—testicular cancer	0.000767	0.00118	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—testicular cancer	0.000767	0.00118	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—testicular cancer	0.000763	0.00117	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—testicular cancer	0.000743	0.00114	CcSEcCtD
Cyclobenzaprine—Nausea—Ifosfamide—testicular cancer	0.000736	0.00113	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Cisplatin—testicular cancer	0.000731	0.00112	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—testicular cancer	0.000729	0.00112	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Etoposide—testicular cancer	0.000721	0.00111	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—testicular cancer	0.00072	0.0011	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—testicular cancer	0.000715	0.0011	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000711	0.00109	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—testicular cancer	0.000709	0.00109	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—testicular cancer	0.000704	0.00108	CcSEcCtD
Cyclobenzaprine—Asthenia—Etoposide—testicular cancer	0.000702	0.00108	CcSEcCtD
Cyclobenzaprine—Pruritus—Etoposide—testicular cancer	0.000693	0.00106	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Epirubicin—testicular cancer	0.00069	0.00106	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—testicular cancer	0.000683	0.00105	CcSEcCtD
Cyclobenzaprine—Vomiting—Cisplatin—testicular cancer	0.000679	0.00104	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—testicular cancer	0.000677	0.00104	CcSEcCtD
Cyclobenzaprine—Rash—Cisplatin—testicular cancer	0.000674	0.00103	CcSEcCtD
Cyclobenzaprine—Dermatitis—Cisplatin—testicular cancer	0.000673	0.00103	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Etoposide—testicular cancer	0.00067	0.00103	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—testicular cancer	0.000667	0.00102	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—testicular cancer	0.000666	0.00102	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—testicular cancer	0.000663	0.00102	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—testicular cancer	0.00066	0.00101	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—testicular cancer	0.000658	0.00101	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—testicular cancer	0.000653	0.001	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—testicular cancer	0.000648	0.000994	CcSEcCtD
Cyclobenzaprine—Dizziness—Etoposide—testicular cancer	0.000647	0.000993	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—testicular cancer	0.000646	0.00099	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—testicular cancer	0.000643	0.000986	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—testicular cancer	0.000638	0.000979	CcSEcCtD
Cyclobenzaprine—Nausea—Cisplatin—testicular cancer	0.000635	0.000974	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—testicular cancer	0.000634	0.000972	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—testicular cancer	0.000632	0.000969	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—testicular cancer	0.000624	0.000957	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—testicular cancer	0.000623	0.000955	CcSEcCtD
Cyclobenzaprine—Vomiting—Etoposide—testicular cancer	0.000622	0.000955	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—testicular cancer	0.000618	0.000948	CcSEcCtD
Cyclobenzaprine—Rash—Etoposide—testicular cancer	0.000617	0.000947	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etoposide—testicular cancer	0.000617	0.000946	CcSEcCtD
Cyclobenzaprine—Headache—Etoposide—testicular cancer	0.000613	0.000941	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—testicular cancer	0.000613	0.00094	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—testicular cancer	0.000612	0.000938	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—testicular cancer	0.000612	0.000938	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—testicular cancer	0.000611	0.000936	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—testicular cancer	0.000609	0.000934	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—testicular cancer	0.000606	0.00093	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—testicular cancer	0.000604	0.000927	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—testicular cancer	0.000604	0.000927	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—testicular cancer	0.000604	0.000927	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—testicular cancer	0.000603	0.000925	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—testicular cancer	0.000602	0.000923	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—testicular cancer	0.000594	0.000911	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—testicular cancer	0.000591	0.000907	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—testicular cancer	0.000591	0.000906	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—testicular cancer	0.000586	0.000899	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—testicular cancer	0.000586	0.000899	CcSEcCtD
Cyclobenzaprine—Convulsion—Epirubicin—testicular cancer	0.000583	0.000894	CcSEcCtD
Cyclobenzaprine—Nausea—Etoposide—testicular cancer	0.000581	0.000892	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—testicular cancer	0.000581	0.00089	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000577	0.000885	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—testicular cancer	0.000574	0.000881	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—testicular cancer	0.000572	0.000878	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—testicular cancer	0.000572	0.000878	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—testicular cancer	0.000572	0.000877	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—testicular cancer	0.00057	0.000875	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—testicular cancer	0.000567	0.00087	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—testicular cancer	0.000566	0.000868	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—testicular cancer	0.000561	0.000861	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—testicular cancer	0.00056	0.000859	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—testicular cancer	0.000559	0.000857	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—testicular cancer	0.000559	0.000857	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—testicular cancer	0.000558	0.000856	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—testicular cancer	0.000557	0.000854	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—testicular cancer	0.000553	0.000849	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—testicular cancer	0.00055	0.000843	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—testicular cancer	0.000549	0.000842	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—testicular cancer	0.000549	0.000842	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—testicular cancer	0.000548	0.00084	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—testicular cancer	0.000547	0.000839	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—testicular cancer	0.00054	0.000828	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—testicular cancer	0.000539	0.000827	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—testicular cancer	0.000537	0.000824	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—testicular cancer	0.000537	0.000824	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—testicular cancer	0.000536	0.000821	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000534	0.000819	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—testicular cancer	0.00053	0.000814	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—testicular cancer	0.00053	0.000813	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—testicular cancer	0.00053	0.000812	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—testicular cancer	0.00053	0.000812	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—testicular cancer	0.000528	0.00081	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—testicular cancer	0.000527	0.000808	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—testicular cancer	0.000523	0.000803	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—testicular cancer	0.000523	0.000802	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—testicular cancer	0.000523	0.000802	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—testicular cancer	0.000521	0.0008	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—testicular cancer	0.000518	0.000795	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—testicular cancer	0.000516	0.000792	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—testicular cancer	0.000513	0.000787	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—testicular cancer	0.000512	0.000785	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—testicular cancer	0.00051	0.000782	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—testicular cancer	0.000508	0.000779	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000508	0.000779	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—testicular cancer	0.000506	0.000775	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.0005	0.000767	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—testicular cancer	0.0005	0.000766	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000497	0.000763	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—testicular cancer	0.000496	0.000761	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—testicular cancer	0.000496	0.00076	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—testicular cancer	0.000493	0.000756	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000491	0.000753	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—testicular cancer	0.000489	0.00075	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—testicular cancer	0.000488	0.000748	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—testicular cancer	0.000484	0.000742	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—testicular cancer	0.000483	0.000741	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—testicular cancer	0.000483	0.000741	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000479	0.000735	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—testicular cancer	0.000477	0.000732	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—testicular cancer	0.000474	0.000728	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—testicular cancer	0.000473	0.000726	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—testicular cancer	0.000469	0.00072	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—testicular cancer	0.000466	0.000715	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—testicular cancer	0.000464	0.000711	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000463	0.00071	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—testicular cancer	0.000459	0.000704	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—testicular cancer	0.000456	0.000699	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—testicular cancer	0.000453	0.000694	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—testicular cancer	0.000452	0.000694	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—testicular cancer	0.000451	0.000692	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000449	0.000688	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—testicular cancer	0.000447	0.000686	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—testicular cancer	0.000441	0.000677	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—testicular cancer	0.000438	0.000671	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—testicular cancer	0.000436	0.000669	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—testicular cancer	0.000434	0.000666	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—testicular cancer	0.000434	0.000665	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—testicular cancer	0.000432	0.000663	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—testicular cancer	0.000421	0.000645	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—testicular cancer	0.000418	0.000642	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000415	0.000637	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—testicular cancer	0.000415	0.000636	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Epirubicin—testicular cancer	0.000404	0.00062	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—testicular cancer	0.000403	0.000619	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—testicular cancer	0.000401	0.000616	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—testicular cancer	0.000401	0.000615	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—testicular cancer	0.000394	0.000604	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—testicular cancer	0.000388	0.000596	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—testicular cancer	0.000388	0.000595	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Epirubicin—testicular cancer	0.000375	0.000576	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—testicular cancer	0.000374	0.000574	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—testicular cancer	0.000373	0.000572	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—testicular cancer	0.00037	0.000567	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—testicular cancer	0.000369	0.000567	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—testicular cancer	0.000367	0.000563	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—testicular cancer	0.000364	0.000559	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—testicular cancer	0.000363	0.000557	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—testicular cancer	0.000359	0.000551	CcSEcCtD
Cyclobenzaprine—Vomiting—Epirubicin—testicular cancer	0.000349	0.000535	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—testicular cancer	0.000348	0.000534	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—testicular cancer	0.000347	0.000533	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—testicular cancer	0.000346	0.000531	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—testicular cancer	0.000346	0.00053	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—testicular cancer	0.000344	0.000527	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—testicular cancer	0.000336	0.000515	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—testicular cancer	0.000326	0.0005	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—testicular cancer	0.000323	0.000495	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—testicular cancer	0.00032	0.000491	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—testicular cancer	0.00032	0.000491	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—testicular cancer	0.000318	0.000488	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—testicular cancer	0.000302	0.000463	CcSEcCtD
